<DOC>
	<DOCNO>NCT01123707</DOCNO>
	<brief_summary>This multicenter , 52-week , open-label study design ass safety tolerability oral aripiprazole/escitalopram combination therapy outpatient major depressive disorder ( MDD ) . Enrollment study eligible subject complete participation Protocol 31-08-255 , 31-08-256 , 31-08-263 ( `` rollover '' subject ) .</brief_summary>
	<brief_title>To Assess Safety Tolerability Oral Aripiprazole/Escitalopram Combination Therapy Patients With Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Subjects participate Protocol 3108255 , 3108256 , 3108263 . Subjects current need involuntary commitment hospitalize â‰¤ 28 day Baseline Visit current major depressive episode . Subjects diagnosis delirium , dementia , amnestic cognitive disorder , schizophrenia , schizoaffective disorder , psychotic disorder , Bipolar I II disorder , Eating disorder ( include anorexia nervosa bulimia ) , obsessive compulsive disorder , panic disorder , posttraumatic stress disorder . Subjects diagnosis borderline , antisocial , paranoid , schizoid , schizotypal histrionic personality disorder . Subjects experience hallucination , delusion , psychotic symptomatology current depressive episode . Subjects meet DSMIVTR criterion substance abuse past 6 month ( prior Baseline Visit ) and/or dependence include past 12 month ( prior Baseline Visit ) , include alcohol benzodiazepine , exclude caffeine nicotine . Subjects two positive drug result cocaine exclude study . Subjects hypothyroidism hyperthyroidism . Subjects significant risk commit suicide base history , investigator 's judgment , and/or evaluation base CSSRS Subjects currently clinically significant neurological , hepatic , renal , metabolic , hematological , immunological , cardiovascular , pulmonary , gastrointestinal disorder . Subjects insulindependent diabetes mellitus ( IDDM ) . Subjects epilepsy significant history seizure disorder , except single childhood febrile seizure , posttraumatic , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>Depression</keyword>
</DOC>